Suppr超能文献

通过脱水-再水化法将血红蛋白包封于脂质体中:囊泡表征及体内行为

Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: vesicle characterization and in vivo behaviour.

作者信息

Brandl M, Gregoriadis G

机构信息

Centre for Drug Delivery Research, School of Pharmacy, London, UK.

出版信息

Biochim Biophys Acta. 1994 Nov 23;1196(1):65-75. doi: 10.1016/0005-2736(94)90296-8.

Abstract

Haemoglobin (Hb) was isolated from human erythrocytes under conditions which maintained NADH-cytochrome-b5 reductase activity and suppressed oxidation of Hb during storage at 4 degrees C (methaemoglobin values < 3% after 29 days). Hb was entrapped into liposomes composed of hydrogenated egg phosphatidylcholine and equimolar cholesterol according to the dehydration/rehydration procedure of Kirby and Gregoriadis ((1984) Biotechnology 2, 979). However, encapsulation of Hb in its intact form was poor (< 5%) as a result of its oxidation and denaturation during freeze-drying. The addition of cryoprotectants and the use of both, higher initial concentrations of Hb and very small void vesicles resulted in Hb-rich dehydration/rehydration vesicles (phospholipid/Hb molar ratio of about 200:1) of the preferred size of 110 nm (mean). Highly homogeneous and small void vesicles as starting material were prepared using the one-step method of Brandl et al. ((1990) Drug Dev. Ind. Pharm. 16, 2167). The cryoprotectants were chosen with respect to their sufficient protection of Hb without affecting its loading into vesicles during freeze-drying and rehydration. 51Cr-labelling of Hb was used for the in vivo monitoring of the fate of Hb-containing vesicles rather than 125I-labelling since the latter induced strong interactions of Hb with liposomes. Upon intravenous administration into rats, liposomal 51Cr-Hb showed greater blood levels and prolonged circulation times in the blood compared to free Hb. The present approach provides high yield entrapment of labile molecules into vesicles of small size known to exhibit long circulation time.

摘要

在能维持NADH-细胞色素b5还原酶活性并抑制血红蛋白(Hb)在4℃储存期间氧化的条件下,从人红细胞中分离出血红蛋白(29天后高铁血红蛋白值<3%)。根据Kirby和Gregoriadis((1984) Biotechnology 2, 979)的脱水/再水化程序,将Hb包裹在由氢化卵磷脂和等摩尔胆固醇组成的脂质体中。然而,由于冻干过程中Hb的氧化和变性,其完整形式的包裹率很低(<5%)。添加冷冻保护剂以及使用更高的Hb初始浓度和非常小的无内容物囊泡,得到了富含Hb的脱水/再水化囊泡(磷脂/Hb摩尔比约为200:1),其优选尺寸为110nm(平均)。使用Brandl等人((1990) Drug Dev. Ind. Pharm. 16, 2167)的一步法制备高度均匀且无内容物的小囊泡作为起始材料。选择冷冻保护剂时考虑到它们能充分保护Hb,同时在冻干和再水化过程中不影响其装入囊泡。使用51Cr标记Hb用于体内监测含Hb囊泡的命运,而不是125I标记,因为后者会诱导Hb与脂质体发生强烈相互作用。与游离Hb相比,脂质体51Cr-Hb静脉注射到大鼠体内后,在血液中的水平更高,循环时间更长。本方法能将不稳定分子高效包裹到已知具有长循环时间的小尺寸囊泡中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验